• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Sullivan James David bought $49,892 worth of shares (285,100 units at $0.17), increasing direct ownership by 175% to 358,500 units (SEC Form 4)

    11/1/23 5:04:18 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology
    Get the next $BKYI alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Sullivan James David

    (Last) (First) (Middle)
    C/O BIO-KEY INTERNATIONAL, INC.
    101 CRAWFORDS CORNER RD, SUITE 4116

    (Street)
    HOLMDEL NJ 07733

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    BIO KEY INTERNATIONAL INC [ BKYI ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) X Other (specify below)
    Chief Legal Officer / SVP Strategy & Compliance
    3. Date of Earliest Transaction (Month/Day/Year)
    10/30/2023
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 10/30/2023 P 228,000 A $0.175 358,500(1) D
    Common Stock 10/30/2023 P 57,100 A $0.175 415,600(1) I Spouse
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Warrant $0.175 10/30/2023 P 228,000 10/31/2023 10/30/2028 common stock 228,000 (2) 246,750 D
    Warrant $0.175 10/30/2023 P 57,100 10/31/2023 10/30/2028 common stock 57,100 (2) 303,850 I Spouse
    Explanation of Responses:
    1. Holdings do not include options to purchase 18,750 shares and warrants to purchase 285,100 shares.
    2. Warrants were purchased as part of a unit with each unit consisting of one share of common stock and one warrant at a purchase price of $0.175 per unit.
    /s/ James Sullivan 11/01/2023
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $BKYI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BKYI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BKYI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Biometric Identity and Access Management Software Solutions Provider BIO-key Announces Two Webcast Investor Presentations: Aegis Capital Thu. May 22 at 11:30am ET and Maxim Group Wed. June 4 at 11am ET

      HOLMDEL, N.J., May 20, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and tokenless, Identity-Bound Biometric (IBB) authentication solutions today announces its participation at the Aegis Capital Corp. 2025 Virtual Conference on Thursday, May 22nd and the Maxim Virtual Tech Conference on Wednesday, June 4th – webcast access details provided below. Aegis Capital Virtual Conference 2025BIO-key PresentationDate/Time: Thursday, May 22, 2025, 11:30 – 11:55 a.m. ETWebcast Link: https://us02web.zoom.us/meeting/register/AfmnLxICTqmjEvoSG9-MMQ#/reg

      5/20/25 7:59:00 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • BIO-key and Cloud Distribution Co. Partner to Expand IAM and Biometric Security Solutions Across the Middle East

      WALL, N.J. and RIYADH, Saudi Arabia, May 19, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication solutions, is pleased to announce a strategic partnership with Cloud Distribution Co., a prominent Value-Added Distributor (VAD) headquartered in Saudi Arabia, with operations across the Middle East. Cloud Distribution joins BIO-key's Channel Alliance Partner (CAP) program to deliver BIO-key's full suite of IAM and biometric authentication solutions to enterprises and public institutions in Saudi Arabia, the UAE, and across the region. This partnership strengthens BIO-key's local capabilities wh

      5/19/25 7:59:00 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • BIO-key Reports Q1'25 Revenue of $1.6M and Improved Cash Position of $3.1M; Hosts Investor Call Tomorrow, Friday May 16th at 10am ET

      HOLMDEL, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and tokenless Identity-Bound Biometric (IBB) authentication, announced results for its first quarter (Q1'25). BIO-key will host an investor call tomorrow, Friday, May 16th at 10:00am ET (details below). BIO-key CEO, Mike DePasquale commented, "Our revenue rose approximately 10% sequentially vs. Q4'24, as we continue our transition to selling high-margin BIO-key branded products in Europe, the Middle East and Africa (EMEA). Year-over-year revenue decreased 25% due to a

      5/15/25 4:15:00 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology

    $BKYI
    SEC Filings

    See more
    • BIO-key International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

      8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)

      5/15/25 4:46:01 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 10-Q filed by BIO-key International Inc.

      10-Q - BIO KEY INTERNATIONAL INC (0001019034) (Filer)

      5/15/25 4:31:41 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 424B3 filed by BIO-key International Inc.

      424B3 - BIO KEY INTERNATIONAL INC (0001019034) (Filer)

      5/12/25 4:31:59 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology

    $BKYI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Williams Cameron E. was granted 3,897 shares, increasing direct ownership by 33% to 15,684 units (SEC Form 4)

      4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

      5/12/25 4:54:08 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • Director Alia Emmanuel was granted 3,897 shares, increasing direct ownership by 31% to 16,323 units (SEC Form 4)

      4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

      5/12/25 4:49:05 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • Director Michel Robert J was granted 3,897 shares, increasing direct ownership by 29% to 17,303 units (SEC Form 4)

      4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

      5/12/25 4:43:34 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology

    $BKYI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by BIO-key International Inc.

      SC 13G/A - BIO KEY INTERNATIONAL INC (0001019034) (Subject)

      11/14/24 5:05:04 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G filed by BIO-key International Inc.

      SC 13G - BIO KEY INTERNATIONAL INC (0001019034) (Subject)

      2/14/24 3:30:35 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G/A filed by BIO-key International Inc. (Amendment)

      SC 13G/A - BIO KEY INTERNATIONAL INC (0001019034) (Subject)

      2/13/24 8:04:15 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology

    $BKYI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Depasquale Michael W bought $3,600 worth of shares (20,000 units at $0.18), increasing direct ownership by 7% to 306,827 units (SEC Form 4)

      4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

      12/4/23 10:12:08 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • Sullivan James David bought $3,300 worth of shares (20,000 units at $0.17), increasing direct ownership by 5% to 388,171 units (SEC Form 4)

      4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

      12/4/23 8:35:57 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • Sullivan James David bought $6,505 worth of shares (39,671 units at $0.16), increasing direct ownership by 12% to 368,171 units (SEC Form 4)

      4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

      11/28/23 1:35:31 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology

    $BKYI
    Financials

    Live finance-specific insights

    See more
    • BIO-key Reports Q1'25 Revenue of $1.6M and Improved Cash Position of $3.1M; Hosts Investor Call Tomorrow, Friday May 16th at 10am ET

      HOLMDEL, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and tokenless Identity-Bound Biometric (IBB) authentication, announced results for its first quarter (Q1'25). BIO-key will host an investor call tomorrow, Friday, May 16th at 10:00am ET (details below). BIO-key CEO, Mike DePasquale commented, "Our revenue rose approximately 10% sequentially vs. Q4'24, as we continue our transition to selling high-margin BIO-key branded products in Europe, the Middle East and Africa (EMEA). Year-over-year revenue decreased 25% due to a

      5/15/25 4:15:00 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • BIO-key, Provider of Identity and Access Management Solutions Enhanced with Biometric Authentication Hosts Q1 Investor Call Fri. May 16th at 10am ET

      HOLMDEL, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of Identity and Access Management solutions with unique Identity-Bound Biometric capabilities, will host its first quarter 2025 investor call on Friday, May 16th at 10 a.m. ET. Results will be released after market close on Thursday. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference call and Q&A session. Call DetailsDate / Time: Friday, May 16th at 10 a.m. ETCall Dial In #:1-877-418-5460 U.S. or 1-412-717-9594 Int'lLive Webcast / Replay:Webcast & Replay Link – Available for 3 monthsAudio Replay:1-877-344-7529 U.S. or 1-412-317-0088 Int'l; code 65

      5/9/25 11:00:08 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • BIO-key Trims 2024 Net Loss 49% to $4.3M, Reflecting Higher Gross Margin and Lower Operating Costs, Offsetting 11% Revenue Decrease Due to Business Transition; Hosts Investor Call Today at 10am ET

      HOLMDEL, N.J., March 27, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced results for its fourth quarter (Q4'24) and year ended December 31, 2024 (2024). BIO-key's 2023 results, which were restated and filed with the Company's 2023 Form 10-K, are reflected in this release for comparison purposes. BIO-key will host an investor call today, Thursday, March 27th at 10:00am ET (details below). BIO-key CEO, Mike DePasquale commented, "From a strategic sta

      3/27/25 7:58:00 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology

    $BKYI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Bio-key upgraded by Maxim Group with a new price target

      Maxim Group upgraded Bio-key from Hold to Buy and set a new price target of $6.00

      3/26/21 7:52:25 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology

    $BKYI
    Leadership Updates

    Live Leadership Updates

    See more
    • BIO-key Partners with Ping Identity to Bring its Cutting-Edge Biometric Authentication to Ping Customers

      DENVER and HOMDEL, N.J., Dec. 11, 2023 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of Identity and Access Management (IAM) solutions including Identity-Bound Biometrics, and Ping Identity, a leading provider of seamless and secure digital experiences, announced today that BIO-key's unique biometric authentication technology is now included on the Ping Identity Integration Directory. The integration enables Ping clients to utilize BIO-key's powerful and seamless biometric authentication solution in combination with the PingOne Cloud Platform. The combined solution streamlines authentication processes and ensures a secure, frictionless user experien

      12/11/23 7:59:02 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • Identity and Access Management Software Provider BIO-key Names Seasoned Financial Services Executive Cameron E. Williams to its Board of Directors

      WALL, N.J., June 02, 2023 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), today announced that it has appointed Cameron E. Williams to its Board of Directors. Mr. Williams has spent over forty years in leading executive officer roles in banking and financial services firms, serving on the board of directors of multiple organizations and more recently, in founding and leading strategic, financial and security consulting firms. Mr. Williams brings deep experience, an ideal skill set, and a broad base of relationships to his role on BIO-key

      6/2/23 8:01:00 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • Identity and Access Management Solutions Provider BIO-key Adds Proven Security Sales Leaders in Planned Senior Management Transition

      WALL, N.J., Jan. 03, 2023 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of Identity and Access Management (IAM) and Identity-Bound Biometric (IBB) solutions, today announced the appointment of Galen Rodgers, Vice President of Channels, and Chad Carter, VP North America Sales. The appointments are effective today, January 3, and are in anticipation of the planned retirement of Chief Revenue Officer Fred Corsentino. A top-performing technology leader, Galen Rodgers, who will report to Chairman & CEO Michael DePasquale, brings 20+ years of experience in channel program development, marketing strategy, value selling, management, cyber security, proces

      1/3/23 8:01:00 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology